Gestational diabetes mellitus (GDM) is the most common metabolic disease of pregnancy and is associated with several perinatal complications. GDM is defined as diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation. In Europe, in 2016, the prevalence of GDM was estimated to be 5.4% (3.8–7.8). It varied depending on maternal age, year of data collection, country, area of Europe, week of gestation at testing, and diagnostic criteria. The Hellenic Endocrine Society and the Hellenic Society of Maternal-Fetal Medicine commissioned an expert group to construct national guidelines on “Diabetes mellitus and pregnancy: Gestational diabetes mellitus.” Following a search for the best available evidence and critical appraisal of the results, the writing group generated a series of consensus recommendations regarding screening tests for the general population, monitoring and management, fetal monitoring, management of preterm labor, planning of labor and delivery, puerperium and breastfeeding, and long-term follow-up of GDM.

妊娠期糖尿病 (GDM) 是妊娠期最常见的代谢疾病，与多种围产期并发症有关。GDM 被定义为在妊娠中期或晚期诊断出的糖尿病，但在妊娠前并非明显的糖尿病。在欧洲，2016 年 GDM 的患病率估计为 5.4% (3.8-7.8)。它因产妇年龄、数据收集年份、国家、欧洲地区、测试时的妊娠周数和诊断标准而异。希腊内分泌学会和希腊母胎医学学会委托一个专家组制定关于“糖尿病和妊娠：妊娠糖尿病”的国家指南。在寻找最佳可用证据并对结果进行批判性评估之后，